8.10 USD
↗ 0.26 (3.25%)PRE MARKET (AS OF 07:31 PM EDT)
Shares of Atrium Therapeutics, Inc. Common Stock (RNA) are trading at $8.10. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 2, 2026.